LoginGet started
Picture of Renalytix logo

RNLX — Renalytix Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock
Balance sheetIncome statementCashflow
Subscribe to view all data

Annual cashflow statement for Renalytix, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

R2019
June 30th
2020
June 30th
2021
June 30th
2022
June 30th
2023
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-7.12-10.6-35.8-49.6-46.2
Depreciation
Amortisation
Non-Cash Items1.14-0.0335.71.254.87
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital0.653-0.6623.360.0166.18
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Payable / Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities-4.2-10.1-24.6-45.7-32.7
Capital Expenditures-19.7-1.31-1.63-0.6940
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-1.990.8270.889—0
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-21.7-0.485-0.741-0.6940
Financing Cash Flow Items——0.111-1.51-0.16
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities33.116.577.225.515.1
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash7.21651.9-23.8-16.7